Chemoimmunotherapy with inotuzumab ozogamicin combined with mini ‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage

ConclusionsThe combination of inotuzumab and low ‐intensity mini‐HCVD chemotherapy with or without blinatumomab shows encouraging results in patients with ALL in first salvage.

Source: Cancer - November 13, 2018 Category: Cancer & Oncology Authors: Elias Jabbour, Koji Sasaki, Farhad Ravandi, Xuelin Huang, Nicholas J. Short, Maria Khouri, Partow Kebriaei, Jan Burger, Joseph Khoury, Jeffrey Jorgensen, Nitin Jain, Marina Konopleva, Guillermo Garcia ‐Manero, Tapan Kadia, Jorge Cortes, J Tags: Original Article Source Type: research